SCI & TECH● LOW1h ago · Sep 8, 2026, 10:57 AM
Roivant climbs on mid-stage trial win for lung disease candidate
Seeking Alpha Tech · global
Roivant's stock rose following a successful mid-stage clinical trial for its lung disease candidate. This positive trial outcome represents a potential advancement in medical treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH20m agoCan dogs sniff out cancer? Indian start-up turns their noses to AIEuroNews [en]SCI & TECH34m agoMajor breakthrough made on famous Millennium maths problemNew ScientistSCI & TECH41m agoShenzhen-Hong Kong-Guangzhou retains crown as world’s top innovation hubSouth China Morning PostSCI & TECH46m agoThey created a Hawaiian shirt that makes you invisible to surveillance camerasClarín